Gilead, Pharmasset merger cleared
The FTC has cleared Gilead Sciences’s $11 billion acquisition of a rival firm, Pharmasset, after Gilead withdrew and refiled its Hart-Scott-Rodino forms in late December. Gilead said it submitted the forms...To view the full article, register now.
Already a subscriber? Click here to view full article